{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:05:27Z","timestamp":1773669927144,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007195","name":"Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      We aim to characterize a novel heterozygous missense variant c.1703A\u2009&gt;\u2009G\/p. (Gln568Arg) in the\n                      <jats:italic>ALDH18A1<\/jats:italic>\n                      gene, identified in a family with autosomal dominant hereditary spastic paraplegia (HSP). We evaluated clinical, neurophysiological, genetic, fluid biomarkers, and neuroimaging expression in different family members with and without the mutation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive multimodal evaluation was performed, including neurological examination, motor and sensory conduction studies, transcranial magnetic stimulation, targeted genetic sequencing, biomarker analysis (amino acid profiling and plasma neurofilament light chain levels (pNfL)), and brain and spinal cord MRI. Mutation pathogenicity was assessed using in silico prediction tools and confirmed by segregation analysis in family members.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The index case, a 53-year-old male, presented with progressive bladder and gait disturbances, with spasticity, weakness, brisk reflexes and reduced deep sensation in the lower limbs. Neurophysiological findings confirmed corticospinal tract involvement. MRI showed selective cerebellar atrophy. Genetic analysis identified the c.1703A\u2009&gt;\u2009G\/p. (Gln568Arg) mutation in the index case and in his father, presenting with similar clinical expression. pNfL was\n                      <jats:underline>numerically<\/jats:underline>\n                      higher in mutation carriers than the healthy brother and daughter of the index case, indicating neuro-axonal damage. Amino acid profiling showed normal levels of ornithine, citrulline, arginine, and proline.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This study expands the spectrum of\n                      <jats:italic>ALDH18A1<\/jats:italic>\n                      -associated HSP, highlighting a novel mutation with a relatively late-onset and mild clinical phenotype. Further functional studies and longitudinal assessments are needed to confirm the pathogenicity of this variant and its potential implications for disease progression and therapeutic strategies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-025-13444-y","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T15:51:57Z","timestamp":1764863517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel missense ALDH18A1 variant in a family with autosomal dominant spastic paraplegia"],"prefix":"10.1007","volume":"273","author":[{"given":"Federica","family":"Novarella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Tessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Criscuolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianmaria","family":"Senerchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Nicolella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Trovato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizia","family":"Falco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirio","family":"Cocozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Scaravilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Ruoppolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Caterino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Brescia Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo Maria","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-3090","authenticated-orcid":false,"given":"Marcello","family":"Moccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"8","key":"13444_CR1","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/brain\/awv143","volume":"138","author":"M Coutelier","year":"2015","unstructured":"Coutelier M et al (2015) Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. Brain 138(8):2191\u20132205. https:\/\/doi.org\/10.1093\/brain\/awv143","journal-title":"Brain"},{"key":"13444_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2014.06.011","author":"T Lo Giudice","year":"2014","unstructured":"Lo Giudice T, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A (2014) Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol. https:\/\/doi.org\/10.1016\/j.expneurol.2014.06.011","journal-title":"Exp Neurol"},{"key":"13444_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031697","author":"A Meyyazhagan","year":"2022","unstructured":"Meyyazhagan A, Orlacchio A (2022) Hereditary spastic paraplegia: an update. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23031697","journal-title":"Int J Mol Sci"},{"key":"13444_CR4","doi-asserted-by":"publisher","unstructured":"de Souza PVS, de Rezende Pinto WBV, de Rezende Batistella GN, Bortholin T, Oliveira ASB (2017) Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks. Springer New York LLC. https:\/\/doi.org\/10.1007\/s12311-016-0803-z.","DOI":"10.1007\/s12311-016-0803-z"},{"key":"13444_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04981-7","author":"S Murala","year":"2021","unstructured":"Murala S, Nagarajan E, Bollu PC (2021) Hereditary spastic paraplegia. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04981-7","journal-title":"Neurol Sci"},{"key":"13444_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00131","author":"E Panza","year":"2019","unstructured":"Panza E, Martinelli D, Magini P, Vici CD, Seri M (2019) Hereditary spastic paraplegia is a common phenotypic finding in ARG1 deficiency, P5CS deficiency and HHH syndrome: three inborn errors of metabolism caused by alteration of an interconnected pathway of glutamate and urea cycle metabolism. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.00131","journal-title":"Front Neurol"},{"issue":"8","key":"13444_CR7","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/acn3.50821","volume":"6","author":"P Magini","year":"2019","unstructured":"Magini P et al (2019) P5CS expression study in a new family with ALDH18A1-associated hereditary spastic paraplegia SPG9. Ann Clin Transl Neurol 6(8):1533\u20131540. https:\/\/doi.org\/10.1002\/acn3.50821","journal-title":"Ann Clin Transl Neurol"},{"key":"13444_CR8","doi-asserted-by":"crossref","unstructured":"Longmire J et al (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Available: https:\/\/academic.oup.com\/nar\/article\/16\/3\/1215\/1234060","DOI":"10.1093\/nar\/16.3.1215"},{"key":"13444_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-025-13223-9","author":"V Nicolella","year":"2025","unstructured":"Nicolella V et al (2025) Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis. J Neurol. https:\/\/doi.org\/10.1007\/s00415-025-13223-9","journal-title":"J Neurol"},{"issue":"11","key":"13444_CR10","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/acn3.51676","volume":"9","author":"L Vermunt","year":"2022","unstructured":"Vermunt L et al (2022) Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface. Ann Clin Transl Neurol 9(11):1832\u20131837. https:\/\/doi.org\/10.1002\/acn3.51676","journal-title":"Ann Clin Transl Neurol"},{"issue":"7993","key":"13444_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen S et al (2024) A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625(7993):92\u2013100. https:\/\/doi.org\/10.1038\/s41586-023-06045-0","journal-title":"Nature"},{"issue":"no. D1","key":"13444_CR12","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M (2019) CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47(D1):D886\u2013D894. https:\/\/doi.org\/10.1093\/nar\/gky1016","journal-title":"Nucleic Acids Res"},{"key":"13444_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70258-8","author":"S Salinas","year":"2008","unstructured":"Salinas S, Proukakis C, Crosby A, Warner TT (2008) Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(08)70258-8","journal-title":"Lancet Neurol"},{"issue":"7","key":"13444_CR14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/acn3.583","volume":"5","author":"C Wilke","year":"2018","unstructured":"Wilke C et al (2018) Serum neurofilament light chain is increased in hereditary spastic paraplegias. Ann Clin Transl Neurol 5(7):876\u2013882. https:\/\/doi.org\/10.1002\/acn3.583","journal-title":"Ann Clin Transl Neurol"},{"key":"13444_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1115-8","author":"JK Fink","year":"2013","unstructured":"Fink JK (2013) Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-013-1115-8","journal-title":"Acta Neuropathol"},{"issue":"9","key":"13444_CR16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s10038-018-0477-0","volume":"63","author":"K Koh","year":"2018","unstructured":"Koh K et al (2018) Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment. J Hum Genet 63(9):1009\u20131013. https:\/\/doi.org\/10.1038\/s10038-018-0477-0","journal-title":"J Hum Genet"},{"key":"13444_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04341-5","author":"C Marelli","year":"2020","unstructured":"Marelli C et al (2020) Autosomal dominant SPG9: intrafamilial variability and onset during pregnancy. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-020-04341-5","journal-title":"Neurol Sci"},{"key":"13444_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac174","author":"J Simren","year":"2022","unstructured":"Simren J et al (2022) Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5\u201390 years. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcac174","journal-title":"Brain Commun"},{"key":"13444_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-021-02682-2","author":"S Cocozza","year":"2021","unstructured":"Cocozza S et al (2021) Conventional MRI findings in hereditary degenerative ataxias: a pictorial review. Neuroradiology. https:\/\/doi.org\/10.1007\/s00234-021-02682-2","journal-title":"Neuroradiology"},{"key":"13444_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-024-01677-y","author":"A Scaravilli","year":"2024","unstructured":"Scaravilli A et al (2024) CHARON: an imaging-based diagnostic algorithm to navigate through the sea of hereditary degenerative ataxias. Cerebellum. https:\/\/doi.org\/10.1007\/s12311-024-01677-y","journal-title":"Cerebellum"},{"key":"13444_CR21","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000279","author":"CA Hewamadduma","year":"2018","unstructured":"Hewamadduma CA et al (2018) \u201cNovel genotype-phenotype and MRI correlations in a large cohort of patients with SPG7 mutations.\u201d Neurol Genet. https:\/\/doi.org\/10.1212\/NXG.0000000000000279","journal-title":"Neurol Genet"},{"key":"13444_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12220","author":"C Marco-Mar\u00edn","year":"2020","unstructured":"Marco-Mar\u00edn C, Escamilla-Honrubia JM, Ll\u00e1cer JL, Seri M, Panza E, Rubio V (2020) \u03941-pyrroline-5-carboxylate synthetase deficiency: an emergent multifaceted urea cycle-related disorder. J Inherit Metab Dis. https:\/\/doi.org\/10.1002\/jimd.12220","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"13444_CR23","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/hmg\/ddac226","volume":"32","author":"MB Colonna","year":"2023","unstructured":"Colonna MB et al (2023) Functional assessment of homozygous ALDH18A1 variants reveals alterations in amino acid and antioxidant metabolism. Hum Mol Genet 32(5):732\u2013744. https:\/\/doi.org\/10.1093\/hmg\/ddac226","journal-title":"Hum Mol Genet"},{"key":"13444_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.627531","author":"YJ Chen","year":"2021","unstructured":"Chen YJ et al (2021) Novel compound missense and intronic splicing mutation in ALDH18A1 causes autosomal recessive spastic paraplegia. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.627531","journal-title":"Front Neurol"},{"key":"13444_CR25","doi-asserted-by":"publisher","first-page":"123562","DOI":"10.1016\/j.jns.2025.123562","volume":"475","author":"F Novarella","year":"2025","unstructured":"Novarella F, Nicolella V, Fiorenza M, Falco F, Monteiro I, Corsini G, Ranucci D, Carotenuto A, Petracca M, Lanzillo R, Salvatore E, Castaldo G, Brescia Morra V, Terracciano D, Moccia M (2025) Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis. J Neurol Sci 475:123562. https:\/\/doi.org\/10.1016\/j.jns.2025.123562","journal-title":"J Neurol Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13444-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13444-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13444-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:57:34Z","timestamp":1773665854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13444-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["13444"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13444-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MM has received research grants from the ECTRIMS-MAGNIMS, the UK MS Society, and Merck; honoraria from Abbvie, Biogen, BMS Celgene, Ipsen, Merck, Novartis, Roche, Sandoz and Sanofi-Genzyme; and salary from Neurology (AAN, US) and Multiple Sclerosis Journal (Sage, UK). SC has received research grants from FISM and Telethon; and has received honoraria from TTLC SRL and Amicus Therapeutics. Vincenzo Brescia Morra has received research grants from the Italian MS Society, and Roche, and honoraria from Bayer, Biogen, BMS Celgene, Merck, Mylan, Novartis, Roche, Sanofi-Genzyme, and Teva.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"6"}}